Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Flexomics helps to bridge genomic and functional analysis.
Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Immunicom is a biotechnology company.
InheRET empowering individuals to accurately identify their risk for hereditary conditions.
Symple Surgical is a medical device company focusing on developing novel therapeutic technologies through controlled microwave ablation.
Veana Therapeutics is a Biotechnology Company based in Oregon.
Pioneering in-human click chemistry against cancer
TumorGen is a biotechnology company.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.
Quiver Bioscience develops medicines for brain disorders using human disease models and AI to advance drug development.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.
National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.
Recent National Cancer Institute portfolio additions include Flexomics, Atrin Pharmaceuticals, Immunicom, InheRET, Symple Surgical. These companies were founded in 2020 or later.